Experience

Davis Polk is advising Roche Holding Ltd. in connection with the sale of an active pharmaceutical ingredients manufacturing facility in Florence, South Carolina, to Patheon N.V. Under the…

Davis Polk is advising J.P. Morgan Securities as financial adviser to Medivation, Inc. in connection with its approximately $14 billion acquisition by Pfizer Inc. The acquisition, which is…

Davis Polk is advising Aetna Inc. in connection with the sale by Aetna and Humana Inc. of certain of their respective Medicare Advantage assets to Molina Healthcare, Inc. for a total…

Davis Polk is advising JP Morgan as financial adviser to Sequenom, Inc. in connection with its $371 million acquisition by Laboratory Corporation of America Holdings. The closing of the…

Davis Polk advised McKesson Corporation on its creation of a new health care information technology company, which will combine substantially all of Change Healthcare Holdings, Inc.’s…

Davis Polk is advising Perella Weinberg as financial adviser to HeartWare International, Inc. in connection with its $1.1 billion acquisition by Medtronic plc. Under the terms of the…

Davis Polk is advising Anacor Pharmaceuticals, Inc. on its approximately $5.2 billion acquisition by Pfizer Inc. The closing of the transaction, which is expected in the third quarter…

Davis Polk is advising Verisk Analytics, Inc. in connection with the $820 million sale of Verisk’s health care services business, Verisk Health, to Veritas Capital. The transaction,…

Davis Polk is advising JP Morgan as financial adviser to Alere Inc. in connection with its $5.8 billion acquisition by Abbott Laboratories. The transaction is subject to the approval of…

Davis Polk is advising JP Morgan as financial adviser to Stryker Corporation in connection with its $2.775 billion acquisition of Sage Products, LLC from Madison Dearborn Partners. The…